Krystal Biotech, Inc.
Krystal Biotech, Inc.（KRYS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
krys · 股价预测 · 17 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 17 位华尔街分析师
Buy
17 位分析师
共识
评级分布
12 个月目标价
High
$371
Consensus
$326
+8.1% upside
Low
$300
Median: $323 · Last Close: $301.76
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$326.20
8.1% upside
High Target
$371
22.9%
Low Target
$300
-0.6%
Current Price
$301.76
as of today
Based on analyst price targets, the KRYS stock price prediction for the next 12 months ranges from $300 to $371. The consensus KRYS price forecast of $326.20 implies 8.1% upside from the current price of $301.76.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $298.84 | ↓ 0.97% |
1-day model range: $297.45–$300.22. Peak: $300.22 (-0.97%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $478 | +58.3% |
| 2028 | $645 | +113.7% |
| 2029 | $780 | +158.5% |
| 2030 | $878 | +191.1% |
| 2031 | — | +213.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KRYS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-05 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-05 | Citigroup | Maintains | Buy→Buy |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Guggenheim | Maintains | Buy→Buy |
| 2026-02-18 | Chardan Capital | Maintains | Buy→Buy |
| 2026-02-18 | Citigroup | Maintains | Buy→Buy |
| 2026-02-17 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Krystal Biotech, Inc. (KRYS) stock. Of the recent 115 rating actions, 3 were upgrades and 2 were downgrades. 17 analysts currently cover KRYS.
分析师推荐趋势
KRYS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$522M
↓ 38.4% YoY
Revenue Next Year
$660M
↑ 26.3% YoY
EPS This Year
$7.75
EPS Next Year
$9.71
↑ 25.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast KRYS EPS of $7.75 for the current fiscal year, based on estimates from 8 analysts. The KRYS revenue forecast is $522M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KRYS 股价预测由两类独立数据源支撑：来自 17 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KRYS 的共识目标价为 $326.20（+8.1% 上行空间），分析师共识为 Buy。
KRYS 的短期预测（明日）为 $298.84（-0.97%）。 KRYS 对 2027 年的股价预测均值为 $478。 KRYS 对 2030 年的预测区间为 $834–$923。
Krystal Biotech, Inc. 在 NASDAQ 上市，代码 KRYS。KRYS 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
KRYS 预测 · 8 个问题根据 17 位华尔街分析师，KRYS 的 12 个月平均目标价为 $326.20，最高 $371.00、最低 $300.00。若有图表，中位目标价可在上方查看。相对当前价 $301.76，隐含约 +8.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.